XML 14 R2.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2024
Dec. 31, 2023
Current Assets:    
Cash and cash equivalents $ 157,168 $ 51,582
Accounts receivable, net 196,089 71,382
Inventory 41,779 25,181
Prepaid expenses and other current assets 25,791 7,987
Total current assets 420,827 156,132
Non-current assets:    
Capitalized software development costs, net 18,616 93,079
Intangible assets, net 1,360,109 1,432,221
Total assets 1,799,552 1,681,432
Current Liabilities:    
Accounts payable 340,962 78,907
Other current liabilities 343,945 196,590
Loans payable 438,254 546,052
Convertible notes payable 1,284,147 1,235,500
Total current liabilities 2,407,308 2,057,049
Total liabilities 2,407,308 2,057,049
Commitments and contingencies (Note 13)
Stockholders’ Deficit:    
Common stock, 900,000,000 shares authorized, $0.0001 par value; 10,806,527 and 9,735,508 shares issued and outstanding at December 31, 2024 and 2023, respectively 1,081 974
Additional paid-in capital 3,722,141 3,606,295
Accumulated deficit (4,331,350) (3,983,258)
Total stockholders’ deficit (607,756) (375,617)
Total liabilities and stockholders’ deficit 1,799,552 1,681,432
Series A Preferred Stock [Member]    
Stockholders’ Deficit:    
Preferred stock, value 108 108
Series A-2 Preferred Stock [Member]    
Stockholders’ Deficit:    
Preferred stock, value $ 264 $ 264